Neurol. praxi. 2019;20(3):208-213 | DOI: 10.36290/neu.2019.114

Depression and migraine: what do they have in common?

MUDr. Sylva Racková, Ph.D.
Psychiatrická ambulance, Plzeň

Depression and migraine are both very frequent disorders. Patients suffering from migraine develop twice often depression and
patient s with depressive disorder suffer more frequent with migraine. Comorbitiy of those both disorders is associated with
worse course, more frequent chronification and is associated with decreased treatment response. Coindidence of migraine and
depression is associated with decreased quality of life and increased suicidality. Antidepressant medication proved to be efective
in the treatment of depression and migraine type headeache.

Keywords: depression, migraine, antidepressants

Published: June 12, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Racková S. Depression and migraine: what do they have in common? Neurol. praxi. 2019;20(3):208-213. doi: 10.36290/neu.2019.114.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adelman LC, Adelman JU, Von Seggern R, Mannix LK. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting. Headache 2000; 40(7): 572-580. Go to original source...
    2. Amiri S, Behnezhad S, Azad E. Migraine headache and depression in adults: a systematic Review and Meta-analysis. Neuropsychiatr 2019; doi: 10.1007/s40211-018-0299-5. Go to original source... Go to PubMed...
    3. Artemenko AR, Kurenkov AL, Nikitin SS, Filatova EG. Duloxetine in the treatment of chronic migraine. Zh Nevrol Psikhiatr Im S S Korsakova 2010; 110(1): 49-54.
    4. Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults. Cochrane Database Syst Rev 2015; 4:CD002919. Go to original source...
    5. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004; 62(10): 1706-1711. Go to original source... Go to PubMed...
    6. Burch R, Rizzoli P, Loder E. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies. Headache 2018; 58(4): 496-505. Go to original source...
    7. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015; 55(1): 21-34. Go to original source...
    8. Deen M, Hansen HD, Hougaard A, N?rgaard M, Eiberg H, Lehel S, Ashina M, Knudsen GM. High brain serotonin levels in migraine between attacks: A 5-HT4 receptor binding PET study. Neuroimage Clin 2018; 18: 97-102. Go to original source... Go to PubMed...
    9. Friedman LE, Gelaye B, Bain PA, Williams MA. A Systematic Review and Meta-Analysis of Migraine and Suicidal Ideation. Clin J Pain 2017; 33(7): 659-665. Go to original source...
    10. Gonçalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry 2016; 87(10):1127-1132. Go to original source...
    11. Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L. A possible new option for migraine management: agomelatine. Clin Neuropharmacol 2013; 36(2): 65-67. Go to original source... Go to PubMed...
    12. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007; 27(11): 1293-1300. Go to original source... Go to PubMed...
    13. Harnod T, Lin CL, Kao CH. Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study. J Clin Med 2018; 7(9): 269. Go to original source...
    14. Harnod T, Lin CL, Kao CH. Survival outcome and mortality rate in patients with migraine: a population-based cohort study. J Headache Pain 2018; 19(1): 57. Go to original source...
    15. Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol 2014; 27(3): 315-324. Go to original source... Go to PubMed...
    16. Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J. A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS One 2015; 10(7): e0130733. Go to original source... Go to PubMed...
    17. Jackson JL, Mancuso JM, Nickoloff S, Bernstein R, Kay C. Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis. J Gen Intern Med 2017; 32(12): 1351-1358. Go to original source...
    18. Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, Berbano E, O'Malley PG. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010; 341: c5222. doi:10.1136/bmj.c5222 Go to original source... Go to PubMed...
    19. Karl? N, Baykan B, Ertaş M, et al. Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. J Headache Pain 2012; 13(7): 557-565. Go to original source...
    20. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health 2013; 34:119-138. Go to original source... Go to PubMed...
    21. Kožený J, Höschl C, Tišanská L. Comorbidity of Migraine and Depression - a Meta-analysis. Cesk Slov Neurol N 2013; 76/109(6): 712-716.
    22. Liu F, Ma T, Che X, Wang Q, Yu S. The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine. Front Neurol 2017; 8: 524. Go to original source... Go to PubMed...
    23. Long R, Zhu Y, Zhou S. Therapeutic role of melatonin in migraine prophylaxis: A systematic review. Medicine (Baltimore) 2019; 98(3): e14099. Go to original source... Go to PubMed...
    24. Minen MT, Begasse De Dhaem O, Kroon Van Diest A, Powers S, Schwedt TJ, Lipton R, Silbersweig D. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 2016; 87: 741-749. Go to original source...
    25. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005; (3): CD002919. Go to original source...
    26. Nović A, K?lves K, O'Dwyer S, De Leo D. Migraine and Suicidal Behaviors: A Systematic Literature Review. Clin J Pain 2016; 32(4): 351-364. Go to original source...
    27. Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol 2018; 75(5): 566-572. Go to original source...
    28. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005; 45(2): 144-152. Go to original source...
    29. Peres MFP, Mercante JPP, Tobo PR, Kamei H, Bigal ME. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain 2017; 18(1): 37. Go to original source...
    30. Plasencia-García BO, Romero-Guillena SL, Quirós-López A, Ruiz-Doblado S. Agomelatine and migraine management: a successfully treated case series. Ther Adv Psychopharmacol 2015; 5(4): 243-245. Go to original source... Go to PubMed...
    31. Sacco S, Merki-Feld GS, AEgidius KL, et al. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). J Headache Pain 2018; 19(1): 76. Go to original source...
    32. Taylor AP, Adelman JU, Freeman MC. Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. Headache 2007; 47(8): 1200-1203. Go to original source...
    33. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001; 111(1): 54-63. Go to original source...
    34. Xu XM, Liu Y, Dong MX, Zou DZ, Wei YD. Tricyclic antidepressants for preventing migraine in adults. Medicine (Baltimore) 2017; 96(22):e6989. Go to original source... Go to PubMed...
    35. Yang Y, Zhao H, Heath AC, Madden PA, Martin NG, Nyholt DR. Shared Genetic Factors Underlie Migraine and Depression. Twin Res Hum Genet 2016; 19(4): 341-350. Go to original source...
    36. Yang Y, Zhao H, Heath AC, Madden PA, Martin NG, Nyholt DR. Familial Aggregation of Migraine and Depression: Insights From a Large Australian Twin Sample. Twin Res Hum Genet 2016; 19(4): 312-321. Go to original source...
    37. Young WB, Bradley KC, Anjum MW, Gebeline-Myers C. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Headache 2013; 53(9): 1430-1437. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.